247 related articles for article (PubMed ID: 32345668)
21. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
[TBL] [Abstract][Full Text] [Related]
22. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.
Adams SL; Tilton K; Kozubek JA; Seshadri S; Delalle I
J Neuropathol Exp Neurol; 2016 Aug; 75(8):779-790. PubMed ID: 27346750
[TBL] [Abstract][Full Text] [Related]
23. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
Franzmeier N; Rubinski A; Neitzel J; Ewers M;
Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Zhang P; Wang D; Zhao Y; Ren S; Gao K; Ye Z; Wang S; Pan CW; Zhu Y; Yan Y; Yang Y; Wu D; He Y; Zhang J; Lu D; Liu X; Yu L; Zhao S; Li Y; Lin D; Wang Y; Wang L; Chen Y; Sun Y; Wang C; Huang H
Nat Med; 2017 Sep; 23(9):1055-1062. PubMed ID: 28805822
[TBL] [Abstract][Full Text] [Related]
26. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
Thomas S; Hoxha K; Tran A; Prendergast GC
J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
[TBL] [Abstract][Full Text] [Related]
27. Identification of speckle-type POZ protein somatic mutations in African American prostate cancer.
Buckles E; Qian C; Tadros A; Majumdar S; Cvitanovic J; Zabaleta J; Estrada J; Wilson J; Liu W
Asian J Androl; 2014; 16(6):829-32. PubMed ID: 24994784
[TBL] [Abstract][Full Text] [Related]
28. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.
Wang J; Jia Y; Zhao S; Zhang X; Wang X; Han X; Wang Y; Ma M; Shi J; Liu L
Oncogene; 2017 Nov; 36(45):6235-6243. PubMed ID: 28714960
[TBL] [Abstract][Full Text] [Related]
29. SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
Boysen G; Rodrigues DN; Rescigno P; Seed G; Dolling D; Riisnaes R; Crespo M; Zafeiriou Z; Sumanasuriya S; Bianchini D; Hunt J; Moloney D; Perez-Lopez R; Tunariu N; Miranda S; Figueiredo I; Ferreira A; Christova R; Gil V; Aziz S; Bertan C; de Oliveira FM; Atkin M; Clarke M; Goodall J; Sharp A; MacDonald T; Rubin MA; Yuan W; Barbieri CE; Carreira S; Mateo J; de Bono JS
Clin Cancer Res; 2018 Nov; 24(22):5585-5593. PubMed ID: 30068710
[No Abstract] [Full Text] [Related]
30. Alzheimer's disease risk gene
Voskobiynyk Y; Roth JR; Cochran JN; Rush T; Carullo NV; Mesina JS; Waqas M; Vollmer RM; Day JJ; McMahon LL; Roberson ED
Elife; 2020 Jul; 9():. PubMed ID: 32657270
[TBL] [Abstract][Full Text] [Related]
31. The emerging role of speckle-type POZ protein (SPOP) in cancer development.
Mani RS
Drug Discov Today; 2014 Sep; 19(9):1498-502. PubMed ID: 25058385
[TBL] [Abstract][Full Text] [Related]
32. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.
Wang H; Barbieri CE; He J; Gao Y; Shi T; Wu C; Schepmoes AA; Fillmore TL; Chae SS; Huang D; Mosquera JM; Qian WJ; Smith RD; Srivastava S; Kagan J; Camp DG; Rodland KD; Rubin MA; Liu T
J Transl Med; 2017 Aug; 15(1):175. PubMed ID: 28810879
[TBL] [Abstract][Full Text] [Related]
33. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
34. BIN1 favors the spreading of Tau via extracellular vesicles.
Crotti A; Sait HR; McAvoy KM; Estrada K; Ergun A; Szak S; Marsh G; Jandreski L; Peterson M; Reynolds TL; Dalkilic-Liddle I; Cameron A; Cahir-McFarland E; Ransohoff RM
Sci Rep; 2019 Jul; 9(1):9477. PubMed ID: 31263146
[TBL] [Abstract][Full Text] [Related]
35. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
36. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
[TBL] [Abstract][Full Text] [Related]
37. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
[TBL] [Abstract][Full Text] [Related]
38. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
39. Association study of the BIN1 and IL-6 genes on Alzheimer's disease.
Ramos Dos Santos L; Belcavello L; Camporez D; Iamonde Maciel de Magalhães C; Zandonade E; Lírio Morelato R; Imbroisi Valle Errera F; Drumond Louro I; Do Carmo Pimentel Batitucci M; de Paula F
Neurosci Lett; 2016 Feb; 614():65-9. PubMed ID: 26733302
[TBL] [Abstract][Full Text] [Related]
40. BIN1 in cancer: biomarker and therapeutic target.
Chen SY; Cao JL; Li KP; Wan S; Yang L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7933-7944. PubMed ID: 36890396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
